Organon & Co. (OGN)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
In fiscal 2025, Organon & Co. reported revenue of $6.22B, down 2.9% from the prior year. The company was profitable, with a net margin of 3.0% and a gross margin of 53.3%. It held $12.87B in total assets against $12.12B in total liabilities.
Key ratios (FY2025)
53.3%
Gross margin
3.0%
Net margin
24.9%
Return on equity
-2.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | $6.53B | $7.78B | — |
| Cost of Revenue | $2.90B | $2.69B | $2.52B | $2.29B | $2.38B | $2.12B | $2.27B | — |
| Gross Profit | $3.31B | $3.71B | $3.75B | $3.88B | — | — | — | — |
| Net Income | $187.00M | $864.00M | $1.02B | $917.00M | $1.35B | $2.16B | $3.22B | — |
| EPS (Diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 | $8.52 | $12.69 | — |
| Total Assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B | $10.11B | — | — |
| Total Liabilities | $12.12B | $12.63B | $12.13B | $11.85B | — | — | — | — |
| Shareholders' Equity | $752.00M | $472.00M | -$70.00M | -$892.00M | -$1.51B | $5.49B | $7.04B | $6.35B |
| Cash & Equivalents | $574.00M | $675.00M | $693.00M | $706.00M | $737.00M | $12.00M | — | — |
| Operating Cash Flow | $700.00M | $939.00M | $799.00M | $858.00M | — | — | — | — |
| Capital Expenditures | $162.00M | $175.00M | $251.00M | $196.00M | $192.00M | $255.00M | $92.00M | — |
| Shares Outstanding | 260.76M | 259.15M | 256.27M | 255.17M | 254.19M | 253.52M | 253.52M | — |
| Dividends Per Share | $0.34 | $1.12 | $1.12 | $1.12 | $0.56 | — | — | — |